← All trials
NCT02693418
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 24, 2016
- Primary completion
- Dec 12, 2016
- Completion date
- Dec 12, 2016
- First posted
- Feb 26, 2016
- Last posted
- Nov 20, 2020
- Enrollment
- 105
- Arms / groups
- 5 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Evofem Inc.Lead sponsor
- Johns Hopkins UniversityCollaborator
- Johns Hopkins UniversityOverall official - principal investigator
- Case Western Reserve UniversityCollaborator
- Johns Hopkins UniversityOfficial
- Clinical Research Management, Inc.Official
- Clinical Research Management, Inc.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.